A Phase Ii Study Of Intermittent Sorafenib With Bevacizumab In Bevacizumab-Naive Epithelial Ovarian Cancer (Eoc) Patients.Elise C. Kohn,Jung-Min Lee,Christina M. Annunziata,Lori M. Minasian,JoAnne Zujewski,S. A. Prindiville,Herbert L. Kotz,Jennifer Squires,Nicole Houston,Helen X. Chen,John J. WrightJOURNAL OF CLINICAL ONCOLOGY(2011)引用 10|浏览23暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要